Gang of 7: Boehringer joins group of com­pa­nies tar­get­ed over drug dis­count pro­gram

Boehringer In­gel­heim on Mon­day joined a grow­ing list of bio­phar­ma com­pa­nies un­der pres­sure from the Biden ad­min­is­tra­tion’s HRSA af­ter re­strict­ing their own par­tic­i­pa­tion in a …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER